PLUS THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Plus Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Plus Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.87M, a 10.7% increase year-over-year.
  • Plus Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$12.9M, a 15% increase year-over-year.
  • Plus Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$13.3M, a 34.3% increase from 2022.
  • Plus Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$20.3M, a 51.3% decline from 2021.
  • Plus Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.4M, a 62.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$12.9M -$2.87M +$345K +10.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$13.2M -$2.94M -$1.46M -98.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$11.8M -$3.26M +$1.54M +32.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$13.3M -$3.81M +$1.85M +32.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$15.2M -$3.22M +$2M +38.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$17.2M -$1.48M +$3.8M +71.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$21M -$4.81M -$689K -16.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$20.3M -$5.66M -$1.5M -36.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$18.8M -$5.22M -$1.5M -40.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 -$17.3M -$5.28M -$2.48M -88.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-31
Q1 2022 -$14.8M -$4.12M -$1.4M -51.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-10-31
Q4 2021 -$13.4M -$4.16M -$568K -15.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$12.8M -$3.72M -$2M -116% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-20
Q2 2021 -$10.8M -$2.8M -$961K -52.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-10-20
Q1 2021 -$9.87M -$2.72M -$1.63M -150% Jan 1, 2021 Mar 31, 2021 10-Q 2022-10-20
Q4 2020 -$8.24M -$3.59M -$4.47M -506% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$3.77M -$1.73M -$2.25M -429% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-21
Q2 2020 -$1.52M -$1.84M +$7.31M +79.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-10-21
Q1 2020 -$8.82M -$1.09M +$2.06M +65.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-10-21
Q4 2019 -$10.9M $884K +$3.12M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-22
Q3 2019 -$14M $526K +$2.86M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-22
Q2 2019 -$16.9M -$9.15M -$5.49M -150% Apr 1, 2019 Jun 30, 2019 10-Q 2020-10-22
Q1 2019 -$11.4M -$3.15M +$1.26M +28.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-10-22
Q4 2018 -$12.6M -$2.24M +$2.05M +47.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$14.7M -$2.33M +$2.48M +51.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$17.2M -$3.66M +$2.39M +39.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$19.6M -$4.41M +$3.14M +41.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$22.7M -$4.29M +$632K +12.9% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-09
Q3 2017 -$23.3M -$4.81M +$577K +10.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$23.9M -$6.05M +$356K +5.56% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$24.3M -$7.54M -$2.21M -41.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$22M -$4.92M -$2.16M -78.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$19.9M -$5.38M -$6.9M -454% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-09
Q2 2016 -$13M -$6.41M -$10.9M -244% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-09
Q1 2016 -$2.13M -$5.34M +$16.6M +75.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-09
Q4 2015 -$18.7M -$2.76M +$3M +52.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 -$21.7M $1.52M +$10.9M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-24
Q2 2015 -$32.6M $4.45M +$16.3M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-24
Q1 2015 -$48.9M -$22M -$11.6M -111% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-24
Q4 2014 -$37.4M -$5.76M +$4.29M +42.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$41.7M -$9.39M -$4.13M -78.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$37.5M -$11.8M -$8.62M -268% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$28.9M -$10.4M -$2.73M -35.6% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
Q4 2013 -$26.2M -$10M -$6.22M -163% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$20M -$5.26M +$5.99M +53.3% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$25.9M -$3.21M +$4.67M +59.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$30.6M -$7.67M +$1.66M +17.8% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$32.3M -$3.82M +$3.08M +44.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$35.4M -$11.2M -$2.91M -34.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$32.4M -$7.88M -$2.75M -53.4% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$29.7M -$9.33M +$2.75M +22.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$32.5M -$6.91M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$8.34M +$2.08M +20% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$5.14M +$239K +4.45% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 -$12.1M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 -$10.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$5.38M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.